Aion Therapeutic Inc. (AION.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.28 Million CAD | N/A |
| 2022 | -256.65 Thousand CAD | 93.28% |
| 2021 | -3.81 Million CAD | 53.8% |
| 2020 | -8.26 Million CAD | -1128.41% |
| 2019 | -672.83 Thousand CAD | 88.01% |
| 2018 | -5.61 Million CAD | -3905.86% |
| 2017 | -140.11 Thousand CAD | 90.7% |
| 2016 | -1.5 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -377.95 Thousand CAD | -108.4% |
| 2023 Q1 | -328.58 Thousand CAD | 54.58% |
| 2023 Q2 | -181.35 Thousand CAD | 44.81% |
| 2022 Q1 | 808.09 Thousand CAD | 149.02% |
| 2022 Q3 | -142 Thousand CAD | 13.7% |
| 2022 Q2 | -164.55 Thousand CAD | -120.36% |
| 2022 Q4 | -723.45 Thousand CAD | -409.45% |
| 2022 FY | -256.65 Thousand CAD | 93.28% |
| 2021 FY | -3.81 Million CAD | 53.8% |
| 2021 Q4 | -1.64 Million CAD | -153.34% |
| 2021 Q3 | -650.73 Thousand CAD | 18.83% |
| 2021 Q2 | -801.74 Thousand CAD | -7.32% |
| 2021 Q1 | -747.08 Thousand CAD | 85.81% |
| 2020 Q1 | -517.64 Thousand CAD | -68.14% |
| 2020 Q3 | -1.59 Million CAD | -80.08% |
| 2020 Q2 | -886.86 Thousand CAD | -71.33% |
| 2020 FY | -8.26 Million CAD | -1128.41% |
| 2020 Q4 | -5.26 Million CAD | -229.59% |
| 2019 Q1 | -530.48 Thousand CAD | 33.37% |
| 2019 Q2 | 412.2 Thousand CAD | 177.7% |
| 2019 Q3 | -246.67 Thousand CAD | -159.84% |
| 2019 Q4 | -307.87 Thousand CAD | -24.81% |
| 2019 FY | -672.83 Thousand CAD | 88.01% |
| 2018 Q2 | -804.78 Thousand CAD | -110.08% |
| 2018 FY | -5.61 Million CAD | -3905.86% |
| 2018 Q4 | -796.14 Thousand CAD | -67.51% |
| 2018 Q3 | -475.28 Thousand CAD | 40.94% |
| 2018 Q1 | -383.08 Thousand CAD | 80.54% |
| 2017 Q4 | -1.96 Million CAD | -891.46% |
| 2017 FY | -140.11 Thousand CAD | 90.7% |
| 2017 Q2 | -673.17 Thousand CAD | 0.0% |
| 2017 Q3 | -198.59 Thousand CAD | 70.5% |
| 2016 FY | -1.5 Million CAD | 0.0% |
| 2015 Q3 | -14.87 Thousand CAD | 0.0% |
| 2015 Q1 | -9044.00 CAD | 0.0% |
| 2014 Q3 | -17.08 Thousand CAD | 0.0% |
| 2014 Q1 | -13.69 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ayurcann Holdings Corp. | -3.96 Million CAD | -58.458% |
| Blueberries Medical Corp. | -1.63 Million CAD | -284.45% |
| The BC Bud Corporation | -1.22 Million CAD | -413.636% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 18.591% |
| CordovaCann Corp. | -6.88 Million CAD | 8.678% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | -52.165% |
| Captor Capital Corp. | -11.38 Million CAD | 44.757% |
| City View Green Holdings Inc. | -2.44 Million CAD | -156.768% |
| 1CM Inc. | -913.85 Thousand CAD | -587.985% |
| Global Hemp Group Inc. | -2.58 Million CAD | -143.639% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -33.128% |
| IM Cannabis Corp. | -9.49 Million CAD | 33.805% |
| Lobe Sciences Ltd. | -4.7 Million CAD | -33.561% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -476.0% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 18.029% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 2915.154% |
| Ovation Science Inc. | -813.14 Thousand CAD | -673.191% |
| Pharmadrug Inc. | -13.2 Million CAD | 52.374% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | -3.321% |
| RAMM Pharma Corp. | -7.72 Million CAD | 18.569% |
| RIV Capital Inc. | -106.76 Million CAD | 94.111% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | -11.899% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 95.474% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 67.535% |
| 1933 Industries Inc. | -13.36 Million CAD | 52.954% |
| Red Light Holland Corp. | -7.62 Million CAD | 17.57% |
| Top Strike Resources Corp. | -1.72 Million CAD | -265.528% |
| Xebra Brands Ltd. | -1.95 Million CAD | -221.205% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -77.372% |